| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.562 | 45.249 | 7.210 | 21.426 | 34.912 | 5.643 | 16.250 | 103.443 | 124.998 | 70.497 |
| Total Income - EUR | 14.214 | 45.249 | 7.210 | 21.426 | 34.913 | 7.980 | 16.250 | 104.629 | 126.591 | 76.385 |
| Total Expenses - EUR | 16.637 | 26.792 | 11.159 | 22.591 | 43.477 | 22.782 | 23.407 | 88.621 | 105.847 | 72.779 |
| Gross Profit/Loss - EUR | -2.423 | 18.457 | -3.949 | -1.165 | -8.565 | -14.802 | -7.157 | 16.008 | 20.744 | 3.606 |
| Net Profit/Loss - EUR | -2.893 | 17.691 | -4.046 | -1.807 | -9.612 | -15.034 | -7.644 | 14.332 | 19.478 | 2.325 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Viokamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.054 | 9.190 | 7.314 | 5.527 | 17.515 | 11.228 | 6.807 | 3.216 | 176 | 1.206 |
| Current Assets | 6.789 | 24.142 | 3.742 | 10.860 | 12.660 | 9.813 | 13.068 | 25.429 | 38.166 | 72.079 |
| Inventories | 825 | 146 | 437 | 1.403 | 4.392 | 6.168 | 8.041 | 19.742 | 28.058 | 52.541 |
| Receivables | 5.770 | 4.078 | 3.185 | 4.107 | 3.052 | 3.608 | 3.934 | 4.793 | 1.738 | 7.290 |
| Cash | 194 | 19.918 | 120 | 5.351 | 5.215 | 38 | 1.093 | 894 | 8.369 | 12.248 |
| Shareholders Funds | -32.854 | -14.828 | -18.535 | -20.003 | -29.227 | -43.707 | -50.382 | -36.206 | -16.619 | -14.201 |
| Social Capital | 45 | 45 | 131 | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 50.697 | 48.160 | 29.591 | 36.390 | 59.402 | 64.748 | 70.257 | 64.851 | 54.960 | 87.487 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Viokamed S.r.l.